KA
NXL icon

Kovack Advisors’s Nexalin Technology NXL Stock Holding History

Kovack Advisors’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.04K Sell
744
-34
-4% -$419 ﹤0.01% 1067
2026
Q1 		$8.2K Hold
778
– – ﹤0.01% 1009
2025
Q4 		$13K Buy
778
+443
+132% +$14.9K ﹤0.01% 1011
2025
Q3 		$9.22K Hold
335
– – ﹤0.01% 609
2025
Q2 		$9.93K Buy
+335
New +$14.1K ﹤0.01% 617

Other funds holding NXL

PEAK6
PEAK6 Chicago, Illinois $48.6B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Kovack Advisors's NXL Position: Q2 2026 in Review

Kovack Advisors reduced its Nexalin Technology (NXL) stake by 4.4% in Q2 2026, selling an estimated $419 and leaving 744 shares worth $8.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Kovack Advisors first reported a position in NXL in Q2 2025 and has held it in 5 quarters since. The position peaked at $13K in Q4 2025. 20 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

  • Kovack Advisors held 744 shares of Nexalin Technology worth $8.04K as of Q2 2026.
  • Kovack Advisors sold 34 Nexalin Technology shares in Q2 2026, an estimated $419.
  • Nexalin Technology made up ﹤0.01% of Kovack Advisors's portfolio in Q2 2026, its #1067 holding.
  • Kovack Advisors first reported a position in Nexalin Technology in Q2 2025 and has held it in 5 quarters since.
  • Kovack Advisors's Nexalin Technology position peaked at $13K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.